BamSEC and AlphaSense Join Forces
Learn More

Biote Corp.

NASDAQ: BTMD    
Share price (11/22/24): $5.98    
Market cap (11/22/24): $325 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 31 pages Lease Agreement Es 432-434 Industrial, LLC Landlord and F.H. Investments, Inc. D/B/a Asteria Health Tenant at 432 Industrial Lane Birmingham, Al 35211 I Lease Agreement
12/34/56
EX-10.3
from 10-Q 10 pages Confidential Separation Agreement and General Release of Claims
12/34/56
EX-10.2
from 10-Q 17 pages [*****] Text Omitted for Confidential Treatment. the Redacted Information Has Been Excluded Because It Is (I) Not Material and (II) the Type of Information That the Registrant Customarily and Actually Treats as Private or Confidential. Settlement Agreement
12/34/56
EX-10.1
from 424B3 41 pages Settlement Agreement
12/34/56
EX-10.1
from 424B3 41 pages Settlement Agreement
12/34/56
EX-10.1
from 10-Q 41 pages Settlement Agreement
12/34/56
EX-10.23
from POS AM 3 pages March 3, 2024 Mary Puncochar Re: Change in Employment Status Dear Mary
12/34/56
EX-10.23
from POS AM 3 pages March 3, 2024 Mary Puncochar Re: Change in Employment Status Dear Mary
12/34/56
EX-10.22
from POS AM 12 pages Employment Agreement
12/34/56
EX-10.22
from POS AM 12 pages Employment Agreement
12/34/56
EX-10.1
from POS AM 3 pages Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from POS AM 3 pages Non-Employee Director Compensation Policy
12/34/56
EX-10.21
from 10-K 9 pages January 8, 2024 Samar Kamdar 7042 Coronado Avenue Dallas, Tx 75214 Re: Transition Agreement Dear Samar: This Letter Sets Forth the Substance of the Transition Agreement (The “Agreement”) Which biote Medical, LLC (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1
12/34/56
EX-10.20
from 10-K 12 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 1 to Warrant Agreement
12/34/56
EX-10.23
from S-4/A 7 pages Tender and Support Agreement
12/34/56
EX-10.23
from S-4 7 pages Tender and Support Agreement
12/34/56
EX-10
from 10-K 29 pages biote Corp. 2022 Equity Incentive Plan
12/34/56
EX-10
from 10-K 4 pages biote Corp. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 9 pages August 26, 2022 (As Modified on August 31, 2022) Robbin Gibbins Re: Transition Agreement Dear Robb: This Letter Sets Forth the Substance of the Transition Agreement (The “Agreement”) Which biote Medical, LLC (The “Company”) Is Offering to You to Aid in Your Employment Transition. 1
12/34/56